Too much focus on smoking status when someone has lung cancer symptoms could lead to people not getting diagnosed as quickly as they should, a charity has warned. Roy Castle Lung Cancer Foundation is ...
Clinical Trials Arena on MSN
Insmed eyes Arikayce label expansion on Phase IIIb lung disease success
The biopharma company will now seek Arikayce’s approval in the US and Japan for use in earlier lines of treatment.
A Roche cancer drug that treats lung cancer with a certain genetic signature now has an additional FDA approval that expands the applications of the blockbuster product. The drug, Alecensa, is already ...
AstraZeneca AZN announced that the FDA expanded the label of its blockbuster cancer drug Imfinzi for a fourth indication in lung cancer. The FDA approved Imfinzi in combination with platinum-based ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results